Amplified Benefit of Clopidogrel Versus Aspirin in Patients With Diabetes Mellitus

Am J Cardiol. 2002 Sep 15;90(6):625-8. doi: 10.1016/s0002-9149(02)02567-5.

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial

MeSH terms

  • Aged
  • Aspirin / therapeutic use*
  • Clopidogrel
  • Diabetes Complications
  • Diabetes Mellitus / drug therapy*
  • Diabetes Mellitus / epidemiology
  • Diabetic Angiopathies / complications
  • Diabetic Angiopathies / drug therapy*
  • Diabetic Angiopathies / epidemiology
  • Endpoint Determination
  • Female
  • Follow-Up Studies
  • Humans
  • Incidence
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Myocardial Infarction / complications
  • Myocardial Infarction / drug therapy
  • Myocardial Infarction / epidemiology
  • Patient Readmission
  • Platelet Aggregation Inhibitors / therapeutic use*
  • Predictive Value of Tests
  • Risk Factors
  • Ticlopidine / analogs & derivatives
  • Ticlopidine / therapeutic use*
  • Treatment Outcome

Substances

  • Platelet Aggregation Inhibitors
  • Clopidogrel
  • Ticlopidine
  • Aspirin